Medicover 관리

관리 기준 확인 4/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Fredrik Rågmark

최고 경영자

€2.7m

총 보상

CEO 급여 비율	39.2%
CEO 임기	27.5yrs
CEO 소유권	1.0%
경영진 평균 재임 기간	3.9yrs
이사회 평균 재임 기간	15yrs

최근 관리 업데이트

Recent updates

CEO 보상 분석

Fredrik Rågmark 의 보수는 Medicover 의 수익과 비교하여 어떻게 변경되었나요?
날짜	총 보상	급여	회사 수익
Mar 31 2024	n/a	n/a	€22m
Dec 31 2023	€3m	€1m	€18m
Sep 30 2023	n/a	n/a	€8m
Jun 30 2023	n/a	n/a	€6m
Mar 31 2023	n/a	n/a	€1m
Dec 31 2022	€3m	€1m	€12m
Sep 30 2022	n/a	n/a	€37m
Jun 30 2022	n/a	n/a	€59m
Mar 31 2022	n/a	n/a	€88m
Dec 31 2021	€2m	€952k	€102m
Sep 30 2021	n/a	n/a	€93m
Jun 30 2021	n/a	n/a	€90m
Mar 31 2021	n/a	n/a	€52m
Dec 31 2020	€2m	€670k	€26m
Sep 30 2020	n/a	n/a	€14m
Jun 30 2020	n/a	n/a	€4m
Mar 31 2020	n/a	n/a	€16m
Dec 31 2019	€1m	€900k	€23m
Sep 30 2019	n/a	n/a	€19m
Jun 30 2019	n/a	n/a	€19m
Mar 31 2019	n/a	n/a	€20m
Dec 31 2018	€1m	€807k	€22m
Sep 30 2018	n/a	n/a	€28m
Jun 30 2018	n/a	n/a	€26m
Mar 31 2018	n/a	n/a	€23m
Dec 31 2017	€921k	€810k	€19m

보상 대 시장: Fredrik 의 총 보상 ($USD 2.94M )은 UK 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 2.69M ).

보상과 수익: Fredrik 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

Fredrik Rågmark (61 yo)

27.5yrs

테뉴어

€2,707,000

보상

Mr. Fredrik Ragmark serves as the Chief Executive Officer of Medicover AB (publ). Mr. Ragmark has been employed with Medicover since 1996. He serves as Managing Director and Board Member of Kalvskär AB.Fr...

리더십 팀

이름	위치	테뉴어	보상	소유권
Fredrik Rågmark	CEO & Director	no data	€2.71m	1.04% SEK 317.5m
Joe Ryan	Chief Financial Officer	no data	데이터 없음	0.96% SEK 292.8m
Jaroslaw Urbanczyk	Chief Information Officer	4.8yrs	데이터 없음	0.0052% SEK 1.6m
Hanna Bjellquist	Head of Investor Relations	no data	데이터 없음	데이터 없음
Jenny Brandt	General Legal Counsel	no data	데이터 없음	0.031% SEK 9.5m
Andrew Vallance-Owen	Chief Marketing Officer	no data	데이터 없음	데이터 없음
Kamila Skorupinski	Group Chief People Officer	less than a year	데이터 없음	데이터 없음
John Stubbington	Chief Operating Officer of Healthcare Services	8.4yrs	데이터 없음	0.53% SEK 161.3m
Staffan Ternstrom	Chief Operating Officer for Diagnostic Services	3.1yrs	데이터 없음	0.033% SEK 10.1m

3.9yrs

평균 재임 기간

59yo

평균 연령

경험이 풍부한 관리: MCOVBS 의 관리팀은 경험 ( 3.9 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Fredrik Rågmark	CEO & Director	27.5yrs	€2.71m	1.04% SEK 317.5m
Robert Jochnick	Independent Director	17.5yrs	€54.60k	1.21% SEK 369.4m
Fredrik Stenmo	Independent Chairman	19.5yrs	€101.50k	4.41% SEK 1.3b
Margareta Nordenvall	Independent Director	23.5yrs	€66.20k	0.060% SEK 18.3m
Arno Bohn	Independent Director	23.5yrs	€63.05k	0.20% SEK 60.9m
Cecil Michael Flemming	Independent Director	9.5yrs	€78.30k	데이터 없음
Anne Berner	Independent Director	2.3yrs	€59.85k	데이터 없음
Azita Shariati	Independent Director	2.3yrs	€63.05k	0.0015% SEK 448.0k
Peder Jochnick	Independent Director	12.5yrs	€54.60k	2.59% SEK 788.6m
Sonali Chandmal	Independent Director	7.5yrs	€71.45k	0.017% SEK 5.1m

15.0yrs

평균 재임 기간

60.5yo

평균 연령

경험이 풍부한 이사회: MCOVBS 의 이사회는 노련하고 경험이 있습니다(평균 재직 기간 15 년).

Medicover 관리

관리 기준 확인 4/4

주요 정보

최근 관리 업데이트

Medicover AB (publ) Announces Nomination Committee for the AGM 2025

Medicover AB (publ), Annual General Meeting, Apr 25, 2025

Medicover AB (publ) Appoints Anand Patel as Chief Financial Officer, Effective October 1, 2024

Insider recently bought kr1.8m worth of stock

Medicover Appoints Kamila Skorupinski as Chief People Officer as of 1 April 2024

Medicover AB (Publ) Announces Resignation of Joe Ryan as Chief Financial Officer

Recent updates

Medicover AB (publ) to Report First Half, 2025 Results on Jul 24, 2025

Medicover AB (publ) Announces Nomination Committee for the AGM 2025

Medicover AB (publ), Annual General Meeting, Apr 25, 2025

Medicover AB (publ) Appoints Anand Patel as Chief Financial Officer, Effective October 1, 2024

Medicover AB (Publ) Provides Revenue Guidance for Year-End 2025

Medicover AB (Publ) Provides Revenue Guidance for Year-End 2025

Dividend of €0.12 announced

Insider recently bought kr1.8m worth of stock

Dividend of €0.12 announced

Full year 2023 earnings released: EPS: €0.12 (vs €0.081 in FY 2022)

Medicover AB (publ) Provides Earnings Guidance for the Financial Year 2025

Medicover Appoints Kamila Skorupinski as Chief People Officer as of 1 April 2024

Medicover AB (Publ) Provides Revenue Targets for by Year-End 2025

Medicover AB (Publ) Announces Resignation of Joe Ryan as Chief Financial Officer

Medicover AB (publ) Announces Nomination Committee for the Annual General Meeting 2024

Medicover AB (publ), Annual General Meeting, Apr 26, 2024

Medicover AB (publ) to Report Q1, 2024 Results on Apr 26, 2024

Insider recently bought kr242k worth of stock

Full year 2022 earnings released: EPS: €0.081 (vs €0.69 in FY 2021)

Full year 2022 earnings released

Medicover AB (publ) Proposes Dividend for 2022

Investor sentiment improves as stock rises 26%

Medicover AB (publ) to Report Q2, 2023 Results on Jul 26, 2023

Medicover AB (publ) to Report Fiscal Year 2022 Results on Feb 17, 2023

Medicover AB (publ) (OM:MCOV B) acquired Übag Mvz Meindentist Gbr.

Medicover AB (publ) (OM:MCOV B) completed the acquisition of Laurus Medical SRL.

Medicover AB (publ), Annual General Meeting, Apr 27, 2023

Medicover AB (publ) (OM:MCOV B) acquired Konzilijum.

Medicover AB (publ) (OM:MCOV B) signed an agreement to acquire Übag Mvz Meindentist Gbr.

Medicover AB (publ) (OM:MCOV B) acquired Kliniki Terapii Allenort Holding Sp. z o.o.

Medicover AB (Publ) Elects Anne Berner and Azita Shariati as Board Members

Full year 2021 earnings released: EPS: €0.69 (vs €0.18 in FY 2020)

General Legal Counsel recently bought kr518k worth of stock

Now 24% undervalued after recent price drop

Medicover AB (publ) Proposes Dividend for the Financial Year 2021, Expected Payable on 6 May 2022

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

Investor sentiment deteriorated over the past week

Medicover AB (publ) (OM:MCOV B) acquired an unknown majority stake in Mediplus Clinic.

Chief Financial Officer recently sold kr1.4m worth of stock

Independent Director recently sold kr2.9m worth of stock

Third quarter 2021 earnings released

Insufficient new directors

Medicover AB (publ) (OM:MCOV B) acquired 70% stake in Klinikk Hanne As for €18.2 million.

Medicover AB (publ) (OM:MCOV B) acquired 88.8% stake in Sellmerdiers Aps from Liza Diers and Anette Sellmer for €13.7 million.

Chief Information Officer recently bought kr161k worth of stock

Investor sentiment improved over the past week

First quarter 2021 earnings released

Full year 2020 earnings released: EPS €0.18 (vs €0.17 in FY 2019)

New 90-day high: kr188

Full year 2020 earnings released: EPS €0.17 (vs €0.17 in FY 2019)

Revenue beats expectations

Diagnostic Services COO Benedikt Von Braunmühl Has Decided to Leave Medinova Diagnostic Services Limited

New 90-day high: kr154

Medicover AB (publ) to Report Q1, 2021 Results on Apr 29, 2021

Medicover AB (publ) to Report Q3, 2020 Results on Nov 06, 2020

CEO 보상 분석

CEO

테뉴어

보상

리더십 팀

평균 재임 기간

평균 연령

이사회 구성원

평균 재임 기간

평균 연령